Opsonin Pharma Limited Sustainability Profile
Opsonin Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and operates extensively across South Asia. Founded in 1990, the company has established itself as a leader in the development and manufacturing of high-quality generic medicines, particularly in the fields of anti-infectives, cardiovascular, and diabetes care. With a commitment to innovation, Opsonin Pharma has achieved significant milestones, including the introduction of several unique formulations that cater to the evolving healthcare needs of the region. The company’s robust portfolio of products is distinguished by its adherence to stringent quality standards and a focus on affordability, making essential medications accessible to a broader population. Opsonin Pharma's dedication to excellence has solidified its market position, earning recognition for its contributions to public health and pharmaceutical advancements in Bangladesh and beyond.
DitchCarbon Score
How does Opsonin Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Opsonin Pharma Limited's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Opsonin Pharma Limited's reported carbon emissions
Opsonin Pharma Limited, headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Opsonin Pharma may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments, it is unclear how Opsonin Pharma aligns with these industry trends. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its environmental responsibility and transparency.
How Carbon Intensive is Opsonin Pharma Limited's Industry?
How Carbon Intensive is Opsonin Pharma Limited's Location?
Opsonin Pharma Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Opsonin Pharma Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.